OPEN Health, a global provider of scientific communications and HEOR & market access services, has announced the acquisition of Acsel Health, a New York-based life science strategy and advisory firm focused on commercial strategy, pricing and market access, and commercial excellence.
Acsel's deep industry expertise, scientific rigor, and actionable analysis drives its success in providing valued partnership to life science companies. These capabilities will complement OPEN Health's existing offering, broadening the range of services it offers to pharma and biotech companies.
Lujing Wang, Managing Partner of Acsel Health, said, "We are thrilled to join OPEN Health and to work with a wider team to solve for today's demands and meet tomorrow's expectations for pharma and biotech customers. With new colleagues and capabilities to partner with, we are equipped to answer the most challenging cross-disciplinary questions in life science across all key therapeutic areas."
"Acsel is an extraordinary addition to OPEN Health. Acsel's expert team and long-standing client relationships significantly strengthen our ability to support the commercialization of our clients' assets and unlock access for patients." said OPEN Health CEO, Rob Barker. "We are excited to welcome Acsel Health into the OPEN Health Group and look forward to working with our new colleagues to offer our clients innovative, scientific solutions around the globe."
Fairmount Partners acted as exclusive financial advisor to Acsel Health. The terms of the transaction were not disclosed.
SOURCE: OPEN Health
© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to TMSalesOperations@arc-network.com. For more information visit Asset & Logo Licensing.